Caribou Biosciences (CRBU) Financials

$1.31

$0.06 (4.40%)

As on 17-Sep-2026 12:38EDT

Market cap

$136 Mln

Revenue (TTM)

$10 Mln

P/E Ratio

--

P/B Ratio

1.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	10.04	11.16	9.99	34.48	13.85	9.60
Cost of Revenue	23.73	3.65	3.93	3.53	3.64	0.98
Gross Profit	-13.02	7.51	6.07	30.95	10.21	8.61
Operating Expenses	96.46	143.71	172.68	147.01	116.61	75.59
Operating Profit (EBIT)	-109.47	-136.19	-166.62	-116.06	-106.40	-66.98
Other Income	--	--	--	--	7.05	0.25
Profit before Tax	-103.95	-148.68	-149.11	-101.88	-99.35	-66.60
Provision for Tax	-0.55	-0.55	-0.01	0.19	0.07	0.32
Profit after Tax (Net Income)	-103.40	-148.13	-149.11	-102.07	-99.42	-66.92
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-99.42	-66.92

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	98.10	122.18	252.95	368.40	300.87	387.83
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	26.70	27.78	29.71	35.51	44.77	28.70
Current Liabilities	17.97	25.41	30.65	28.30	28.13	25.83
Total Liabilities	160.75	175.37	313.31	432.21	373.77	442.36

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	26.18	30.14	93.94	93.37	113.52	51.16
Current Assets	116.60	145.23	219.38	338.84	260.25	391.19
Total Assets	160.75	175.37	313.31	432.21	373.77	442.36
Total Debt*	26.66	27.23	26.49	27.11	27.75	0.26
Net Current Assets	98.62	119.82	188.73	310.54	232.12	365.36

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-110.99	-138.20	-93.29	-90.97	-32.52
Cash Flow from Investing Activities	--	102.24	86.61	-68.18	-93.25	-176.40
Cash from Financing Activities	--	4.82	16.72	154.30	2.13	433.43
Net Cash Inflow / Outflow	--	--	--	--	-182.08	224.51

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.08	-1.57	-1.65	-1.15	-1.63	-1.11
Cash EPS ($)	--	-1.53	-1.61	-1.12	-1.60	-1.10
Adjusted Book Value ($)	--	1.29	2.80	4.17	4.93	6.44
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.17	-1.53	-1.05	-1.49	-0.54
Free Cash Flow per Share ($)	--	-1.19	-1.60	-1.19	-1.61	-0.59

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-69.08	-44.18	-28.19	-27.74	-36.55
ROE (%)	-93.88	-78.97	-47.99	-30.50	-28.87	-36.73
ROA (%)	-50.37	-60.62	-40.00	-25.33	-24.36	-27.98
EBIT Margin (%)	-793.93	-1,332.33	-1,492.04	-295.49	-717.28	-693.83
Net Margin (%)	-1,030.42	-1,327.40	-1,491.95	-296.05	-475.72	-679.56
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	10.02	0.12	-0.71	1.49	0.44	-0.22
EBIT Growth (%)	46.31	0.29	-46.37	-2.54	-49.19	-84.44
Net Profit Growth (%)	37.05	0.66	-46.08	-2.66	-48.56	-95.07
EPS Growth (%)	39.78	0.05	-0.43	0.29	-0.47	0.10
Book Value Growth (%)	-45.60	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.01	-0.96	-4.96	-3.85	-13.57
Price / Book Value	1.48	1.23	0.57	1.38	1.27	2.34
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-36.94	-0.26	0.27	-2.08	-1.70	-8.12
Close Price ($)	1.76	1.59	1.59	5.73	6.28	15.09
High Price ($)	3.54	3.54	8.33	8.59	15.85	32.65
Low Price ($)	1.22	0.66	1.50	3.44	4.89	14.17
Market Cap ($ Cr)	136.15	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.22	0.10	0.07	0.09	0.00
Short term debt to equity ratio	0.01	0.01	0.01	0.00	0.00	0.00
Current Ratio	6.49	5.71	7.16	11.97	9.25	15.15
Quick Ratio	6.49	--	--	--	11.48	16.35
Interest Coverage	--	--	--	--	-11.64	-8,324.25

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	19.34	26.70	32.53	11.19	33.67	84.64
Asset Turnover	0.05	0.05	0.03	0.09	0.03	0.04
Receivable days	--	101.96	129.92	45.15	168.61	252.76
Inventory Days	--	--	--	-6,483.42	-4,698.89	-5,322.48
Payable days	--	413.80	260.24	221.02	257.61	1,223.25
Cash Conversion Cycle	--	--	--	-6,659.29	-4,787.90	-6,292.97

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.